HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marc A Riedl Selected Research

Hereditary Angioedemas

1/2022Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study.
1/2022Inhibition of Prekallikrein for Hereditary Angioedema.
11/2021COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications.
10/2021Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study.
1/2021Patient perspectives on the treatment burden of injectable medication for hereditary angioedema.
1/2021Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial.
1/2021Androgen use in hereditary angioedema: A critical appraisal and approaches to transitioning from androgens to other therapies.
1/2021Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study.
1/2021Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.
11/2020Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marc A Riedl Research Topics

Disease

28Hereditary Angioedemas
01/2022 - 01/2011
12Angioedema
01/2022 - 01/2011
5Hypersensitivity (Allergy)
09/2017 - 11/2003
4Inflammation (Inflammations)
10/2017 - 04/2008
4Asthma (Bronchial Asthma)
02/2012 - 02/2008
2Infections
11/2021 - 01/2017
2Anaphylaxis (Anaphylactic Shock)
09/2017 - 02/2014
2Headache (Headaches)
09/2017 - 04/2015
1COVID-19
11/2021
1Abdominal Pain (Pain, Abdominal)
01/2021
1Back Pain (Backache)
01/2021
1Vomiting
01/2021
1Diarrhea
01/2021
1Acquired Immunodeficiency Syndrome (AIDS)
11/2020
1Wounds and Injuries (Trauma)
10/2020
1Rare Diseases (Rare Disease)
02/2019
1Hereditary Angioedema Types I and II
11/2018
1Injection Site Reaction
11/2018
1Dizziness (Lightheadedness)
11/2018
1Common Variable Immunodeficiency
10/2017
1Fatigue
09/2017
1Thrombosis (Thrombus)
01/2017
1Critical Illness (Critically Ill)
07/2015
1Edema (Dropsy)
05/2015
1Menstruation Disturbances
04/2015
1Muscle Cramp (Cramp)
04/2015
1Hepatocellular Carcinoma (Hepatoma)
04/2015
1Virilism (Virilization)
04/2015
1Weight Gain
04/2015
1Adenoma (Adenomas)
04/2015
1Laryngeal Edema
11/2013
1Symptom Flare Up
01/2013
1Protein Deficiency
08/2011
1Rhinosinusitis
02/2010
1Drug Hypersensitivity (Drug Allergy)
11/2003

Drug/Important Bio-Agent (IBA)

8Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA
02/2019 - 01/2012
7lanadelumabIBA
01/2022 - 01/2017
6Plasma KallikreinIBA
11/2021 - 01/2017
3BradykininIBA
11/2018 - 09/2013
3Penicillins (Penicillin)FDA Link
01/2017 - 11/2003
2icatibantIBA
11/2021 - 03/2017
2KininsIBA
11/2021 - 02/2019
2AndrogensIBA
01/2021 - 04/2015
2Kallikreins (Kallikrein)IBA
02/2019 - 11/2018
2Monoclonal AntibodiesIBA
11/2018 - 01/2017
2Proteins (Proteins, Gene)FDA Link
11/2018 - 01/2011
2Histamine (Histamine Dihydrochloride)FDA Link
11/2018 - 07/2015
2AntibodiesIBA
09/2017 - 07/2017
2Estrogens (Estrogen)FDA Link
09/2013 - 01/2013
2Immunoglobulin E (IgE)IBA
02/2012 - 11/2003
2AntioxidantsIBA
02/2010 - 02/2008
2Environmental Pollutants (Pollutants, Environmental)IBA
03/2009 - 04/2008
1PrekallikreinIBA
01/2022
1donidalorsenIBA
01/2022
1Complement System Proteins (Complement)IBA
11/2021
1Tissue Kallikreins (Tissue Kallikrein)IBA
11/2021
1berotralstatIBA
01/2021
1SDMIBA
11/2020
1Biomarkers (Surrogate Marker)IBA
11/2018
1vedolizumabIBA
10/2017
1Pharmaceutical PreparationsIBA
07/2017
1Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
11/2016
1SteroidsIBA
07/2015
1LipidsIBA
04/2015
1Stanozolol (Winstrol)FDA Link
04/2015
1Danazol (Azol)FDA LinkGeneric
04/2015
1Creatine Kinase (Creatine Phosphokinase)IBA
04/2015
1Neutralizing AntibodiesIBA
02/2014
1Contraceptive Agents (Contraceptives)IBA
01/2013
1AllergensIBA
02/2012
1CytokinesIBA
02/2012
1ChemokinesIBA
02/2012
1Vehicle Emissions (Emissions, Vehicle)IBA
02/2012
1Serine Proteases (Serine Protease)IBA
08/2011
1VitaminsIBA
02/2010
1Oxidants (Oxidizing Agents)IBA
03/2009
1OzoneIBA
03/2009
1FullerenesIBA
02/2008
1Carbapenems (Carbapenem Antibiotics)IBA
11/2003
1Cephalosporins (Cephalosporin Antibiotics)IBA
11/2003

Therapy/Procedure

16Therapeutics
07/2021 - 02/2008
1Injections
01/2021
1Oral Hygiene (Dental Hygiene)
10/2020
1Dental Care
10/2020
1Polypharmacy
01/2020
1Self Administration (Administration, Self)
03/2017
1Intravenous Injections
11/2016
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2013